Our new case study, Increased patient compliance with colon cancer screening through use of at-home test kits, presents the positive impact one provider-payer partnership had on colon cancer screening rates with InSure® FIT collection kits.
By enabling an easy-to-use, self-administered collection method in the home without the need for food or medicinal restrictions, the team saw multiple benefits:
- Increased screening test completion rates by 17 percent
- Five patients were diagnosed with adenomas, a condition with variable malignant potential
- Based on a study that estimates the mean total colon cancer cost per Medicare patient one year after diagnosis at $29,1961, the program was deemed to be highly cost effective
1. Luo Z, Bradley CJ, Dahman BA, Gardiner JC. Colon cancer treatment costs for Medicare and dually eligible beneficiaries. Health Care Financ Rev. 2010 Fall;31(1):35-50.